ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9397
-0.26%
Brent Oil
83.645
0.63%
Bitcoin
65,300.62
2.03%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Crinetics Pharmaceuticals Inc (CRNX)

  7. Crinetics Pharmaceuticals Inc (CRNX) Noticias

CRNX Crinetics Pharmaceuticals Inc

47.20
0.00 (0.00%)
Pre Mercado
Última actualización: 03:05:09
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Crinetics Pharmaceuticals Inc CRNX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 47.20 03:05:09
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
47.20
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
11/3/202415:15EDGAR2Form D - Notice of Exempt Offering of Securities
06/3/202419:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202419:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202419:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202419:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202418:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202418:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202415:41EDGAR2Form S-8 POS - Securities to be offered to employees in..
28/2/202415:09EDGAR2Form 8-K - Current report
14/2/202415:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202416:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202412:03EDGAR2Form 144 - Report of proposed sale of securities
12/1/202415:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202411:10EDGAR2Form 144 - Report of proposed sale of securities
08/1/202407:03EDGAR2Form 8-K - Current report
04/1/202415:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202415:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202415:11EDGAR2Form 144 - Report of proposed sale of securities
02/1/202415:44EDGAR2Form 144 - Report of proposed sale of securities
27/12/202316:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202310:47EDGAR2Form 144 - Report of proposed sale of securities
22/12/202317:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202316:28EDGAR2Form 144 - Report of proposed sale of securities
18/12/202315:12EDGAR2Form 8-K - Current report
13/12/202315:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202315:35EDGAR2Form 8-K - Current report
11/12/202312:48EDGAR2Form 144 - Report of proposed sale of securities
29/11/202315:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202310:40EDGAR2Form 144 - Report of proposed sale of securities
13/11/202315:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202315:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/11/202315:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202315:04EDGAR2Form 8-K - Current report
06/11/202317:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202318:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202315:00EDGAR2Form 144 - Report of proposed sale of securities
02/11/202315:02EDGAR2Form 144 - Report of proposed sale of securities
01/11/202315:44EDGAR2Form 144 - Report of proposed sale of securities
13/9/202316:23EDGAR2Form 8-K - Current report
13/9/202316:19EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/9/202315:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/9/202305:05EDGAR2Form 8-K - Current report
16/8/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202306:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202306:01EDGAR2Form 8-K - Current report
13/7/202315:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/7/202315:14EDGAR2Form 144 - Report of proposed sale of securities
12/7/202315:25EDGAR2Form 144 - Report of proposed sale of securities
11/7/202315:39EDGAR2Form 144 - Report of proposed sale of securities

Su Consulta Reciente

NASDAQ
CRNX
Crinetics Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados